loading...| Preferred Name |
anakinra |
|
| Synonyms |
|
|
| ID |
http://purl.obolibrary.org/obo/dinto_DB00026 |
|
| AHFScode |
92:00.00 |
|
| ATCCode |
L04AC03 |
|
| blocks | ||
| CASRN |
143090-92-0 |
|
| DBBrand |
kineret (amgen inc) |
|
| DBSynonym |
icil-1ra il1 inhibitor il-1ra irap interleukin-1 receptor antagonist protein precursor il-1rn |
|
| Definition |
Anakinra is a recombinant, nonglycosylated human interleukin-1 receptor antagonist (IL-1Ra). The difference between anakinra and the native human IL-1Ra is that anakinra has an extra methionine residue at the amino terminus. It is manufactured by using the E. coli expression system. Anakinra is composed of 153 amino acid residues. FDA approved on November 14, 2001. |
|
| has pharmacological target | ||
| label |
anakinra |
|
| may interact with |
http://purl.obolibrary.org/obo/CHEBI_9513 http://purl.obolibrary.org/obo/dinto_DB06674 http://purl.obolibrary.org/obo/dinto_DB08904 http://purl.obolibrary.org/obo/dinto_DB06372 |
|
| prefixIRI |
obo2:dinto_DB00026 |
|
| prefLabel |
anakinra |
|
| xref |
Drugs.com:http://www.drugs.com/cdi/anakinra.html GenBank:M55646 Drugs Product Database (DPD):2245913 National Drug Code Directory:66658-234-28 PharmGKB:PA10799 RxList:http://www.rxlist.com/cgi/generic/anakinra.htm Wikipedia:http://en.wikipedia.org/wiki/Anakinra UniProtKB:P18510 |
|
| subClassOf |